This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

S&P Capital IQ Picks ICLR Focus Stock Of The Week

NEW YORK, July 30, 2012 /PRNewswire/ -- Icon plc (NASDAQ: ICLR: $24) has been picked by S&P Capital IQ as its Focus Stock of the Week. ICLR's American depositary shares (ADSs) carry S&P Capital IQ's highest investment recommendation of 5-STARS, or Strong Buy.  ICLR is a leading global contract research organization (CRO) providing outsourced clinical research and development services to the pharmaceutical, biotechnology, and medical devices industries. 

"Large pharmaceutical companies are continually seeking to drive efficiencies in their drug development processes to reduce costs associated with the development of new drug candidates and accelerate time to market," said Jeffrey Loo, equity analyst at S&P Capital IQ.  "This has resulted in pharmaceutical firms increasingly outsourcing various research and development functions to CROs, and we believe the main beneficiaries are the larger global CROs such as ICLR."

To view a video of Mr. Loo discussing ICLR click on the following link.    Weblink to video



About S&P Capital IQ S&P Capital IQ, a business line of the McGraw-Hill Companies (NYSE: MHP), is a leading provider of multi-asset class and real time data, research and analytics to institutional investors, investment and commercial banks, investment advisors and wealth managers, corporations and universities around the world. We provide a broad suite of capabilities designed to help track performance, generate alpha, identify new trading and investment ideas, and perform risk analysis and mitigation strategies. Through leading desktop solutions such as Capital IQ, Global Credit Portal and MarketScope Advisor desktops; enterprise solutions such as S&P Valuations, and Compustat; and research offerings, including Leveraged Commentary & Data, Global Market Intelligence, and company and fund research, S&P Capital IQ sharpens financial intelligence into the wisdom today's investors need.  For more information visit www.spcapitaliq.com.



1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,959.19 -78.78 -0.44%
S&P 500 2,095.63 -13.29 -0.63%
NASDAQ 5,008.0410 -52.2050 -1.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs